產(chǎn)品供應(yīng)地夫可特

  • 發(fā)布日期：2020-09-01
  • 有效期限：30天
湖北藝康源化工有限公司 VIP
238-483-7
C23H29NO4
383.48
回上一頁 在線詢盤 打印本頁
詳細(xì)信息
  • ;地夫可特;地夫可特中間體;地那查特;
  • Deflazacort
  • ;DEFLAZACORT;Deflazacort intermediate(D5);11b,21-Dihydroxy-2'-methyl-5'bH-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione 21-acetate;deflazacort intermediate;(4AR,4BS,5S,6AS,9AR,10AS,10BS)-6B-ACETYL-5-HYDROXY-4A,6A,8-TRIMETHYL-4A,4B,5,6,6A,6B,9A,10,10A,10B,11,12-DODECAHYDRO-9-OXA-7-AZA-PENTALENO[2,1-A]PHENANTHREN-2-ONE;2-(5-hydroxy-4a,6a,8-trimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]oxazol-6b-yl)-2-oxoethyl acetate;2-[(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-4a,6a,8-trimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]oxazol-6b-yl]-2-oxoethyl acetate;(4aR,4bS,5S,6aS,9aR,10aS,10bS)-6b-acetyl-5-hydroxy-4a,6a,8-trimethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]oxazol-2-one;(11β,16β)-11-hydroxy-2-methyl-5β-H-progna-1,4-dieno[17,16-d]Oxazolo-3,20-dione;PREGNA-1,4-DIENE-11B-OL-17A,16A-D-2-METHYL-OXAZOLINE-3,20-DIONE;
  • InChI=1/C23H29NO4/c1-12(25)23-19(28-13(2)24-23)10-17-16-6-5-14-9-15(26)7-8-21(14,3)20(16)18(27)11-22(17,23)4/h7-9,16-20,27H,5-6,10-11H2,1-4H3/t16-,17-,18-,19+,20+,21-,22-,23?/m0/s1
  • 1.39g/cm3
  • 544.2°C at 760 mmHg
  • 282.9°C
  • 地夫可特 藥物名稱： 地夫可特 英文名稱： Deflazacort 中文同義詞: 地夫可特;地那查可特;地氟可特;(1LΒ,16Β)-21-乙酰氧基-11-羥基-2'-甲基-5'H-娠烷-1,4-二烯并[17,16-D]噁唑-3,20二酮;去氟可特 英文名稱: 11b,21-Dihydroxy-2'-methyl-5'bH-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione 21-acetate 分子式:C25H31NO6 分子量:441.52 CAS:14484-47-0 含量：98% 包裝：1KG/聽 外觀性狀,白色或類白色結(jié)晶粉末 用途：具有抗炎、抗過敏作用，相當(dāng)于潑尼松龍10～20倍，用于腎上腺皮質(zhì)機(jī)能減退、自身免疫性疾病、過敏性疾病及血液系統(tǒng)疾病等
  • 包裝：鋁罐
  • CAS NO：14484-47-0
    產(chǎn)品規(guī)格：醫(yī)藥級

免責(zé)聲明：以上所展示的信息由企業(yè)自行提供，內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布企業(yè)負(fù)責(zé)，化工網(wǎng)對此不承擔(dān)任何保證責(zé)任。我們原則上建議您選擇化工網(wǎng)高級會員或VIP會員。